Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Medulloblastoma is the most common brain tumor in children. It is treated with a combination of surgical resection, chemotherapy and radiation. Radiation to a child’s brain can have harmful side effects that may have implications in later development. We intend to use molecular gene expression to validate our findings from BC Children’s Hospital regarding low and high risk tumor subgroups. Along with this, we will analyze the expression of polo-like kinase 1 (PLK1), which may be a key protein for drug therapy development to treat high risk patients. In addition, we will investigate the underlying molecular characteristics of the highest risk medulloblastoma tumor subgroup by expanding our gene target panel to include epigenetic regulatory proteins with the goal of developing personalized cancer therapy. Molecular gene expression and clinical outcome will be correlated to better understand trends in this disease. We hope to avoid irradiating mild cases unnecessarily while ensuring aggressive treatment for poor prognosis medulloblastomas.
Dr. Sandra E. Dunn
Joanna Triscott
Hannah's Heroes Foundation
Biology
Life sciences
University of British Columbia
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.